Inherited blood coagulation disorder
MONDO:0021181Hemorrhagic and thrombotic disorders that occur as a consequence of inherited abnormalities in blood coagulation.
Also known as: coagulation disorder, hereditary, coagulation disorder, inherited, coagulation disorders, hereditary, coagulation disorders, inherited, hereditary blood coagulation disease, hereditary blood coagulation disorders, hereditary coagulation disorder, hereditary coagulation disorders
326 clinical trials for this condition and its sub-types, 8 tagged with Inherited blood coagulation disorder itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Inherited blood coagulation disorder
-
Hemophilia A 180 trials
5 sub-types
- Severe hemophilia A 50 trials
- Moderately severe hemophilia A 4 trials
- Mild hemophilia A 2 trials
- Hemophilia A with vascular abnormality 0 trials
- Symptomatic form of hemophilia A in female carriers 0 trials
-
Hemophilia B 84 trials · 91 incl. sub-types
4 sub-types
- Severe hemophilia B 9 trials
- Moderately severe hemophilia B 2 trials
- Mild hemophilia B 1 trial
- Symptomatic form of hemophilia B in female carriers 0 trials
-
Hereditary von Willebrand disease 18 trials · 29 incl. sub-types
5 sub-types
- Von Willebrand disease 3 9 trials
- Von Willebrand disease 2 4 trials · 5 incl. sub-types Sub-types →
- Von Willebrand disease 1 3 trials
- Von Willebrand disease, X-linked form 0 trials
- Platelet-type von Willebrand disease 0 trials
-
Inherited thrombophilia 0 trials · 28 incl. sub-types
12 sub-types
- Thrombophilia due to thrombin defect 19 trials
- Thrombophilia due to activated protein C resistance 5 trials
- Hereditary antithrombin deficiency 3 trials
- Hereditary thrombophilia due to congenital protein C deficiency 1 trial Sub-types →
- Factor 5 excess with spontaneous thrombosis 0 trials
- Heparin cofactor 2 deficiency 0 trials
- Hereditary thrombophilia due to congenital histidine-rich (poly-L) glycoprotein deficiency 0 trials
- Hereditary thrombophilia due to congenital protein S deficiency 0 trials Sub-types →
- Thrombomodulin-related bleeding disorder 0 trials
- Thrombophilia, X-linked, due to factor 8 defect 0 trials
- Thrombophilia, X-linked, due to factor 9 defect 0 trials
- Thrombophilia, familial, due to decreased release of tissue plasminogen activator 0 trials
-
Hereditary hemolytic uremic syndrome 0 trials · 19 incl. sub-types
2 sub-types
-
Wiskott-Aldrich syndrome 10 trials
-
Glanzmann thrombasthenia 8 trials
2 sub-types
- Glanzmann thrombasthenia 1 7 trials
- Glanzmann thrombasthenia 2 0 trials
-
Platelet-type bleeding disorder 10 8 trials
-
Hereditary thrombocytopenia and hematologic cancer predisposition syndrome 1 trial · 5 incl. sub-types
2 sub-types
-
Hermansky-Pudlak syndrome 4 trials
9 sub-types
- Hermansky-Pudlak syndrome with pulmonary fibrosis 0 trials · 1 incl. sub-types Sub-types →
- Hermansky-Pudlak syndrome 10 0 trials
- Hermansky-Pudlak syndrome 11 0 trials
- Hermansky-Pudlak syndrome 2 0 trials
- Hermansky-Pudlak syndrome 7 0 trials
- Hermansky-Pudlak syndrome 8 0 trials
- Hermansky-Pudlak syndrome 9 0 trials
- Hermansky-Pudlak syndrome without pulmonary fibrosis 0 trials Sub-types →
- Kotzot-Richter syndrome 0 trials
-
Congenital vitamin K-dependent coagulation factors deficiency 0 trials · 4 incl. sub-types
5 sub-types
-
Congenital factor XII deficiency 1 trial
-
Hypoplasminogenemia 1 trial
-
Scott syndrome 0 trials
-
Tatsumi factor deficiency 0 trials
-
Alpha-2-plasmin inhibitor deficiency 0 trials
-
Congenital factor V deficiency 0 trials
-
Congenital factor XI deficiency 0 trials
-
Dysplasminogenemia 0 trials
-
Familial thrombomodulin anomalies 0 trials
-
Inherited prekallikrein deficiency 0 trials
-
Plasminogen deficiency, type II 0 trials
-
Platelet-type bleeding disorder 12 0 trials
-
Platelet-type bleeding disorder 14 0 trials
-
Platelet-type bleeding disorder 16 0 trials
-
Platelet-type bleeding disorder 18 0 trials
-
Platelet-type bleeding disorder 8 0 trials
Most studied deeper sub-types
-
One-Time gene therapy could free hemophilia patients from frequent infusions
Disease control OngoingThis study tests a one-time gene therapy (valoctocogene roxaparvovec) in 6 Japanese men with severe hemophilia A. The goal is to help their bodies produce their own clotting factor, reducing or stopping the need for regular factor VIII infusions. Participants will be monitored fo…
Phase 3 • Sponsor: BioMarin Pharmaceutical • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Gene therapy for hemophilia a: how long does it last?
Disease control By invitation onlyThis study checks the long-term safety and effectiveness of a one-time gene therapy (BMN 270) for people with severe hemophilia A. Participants from earlier BioMarin trials will be followed for many years to see if the treatment continues to work and remains safe. The goal is to …
Sponsor: BioMarin Pharmaceutical • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC